The Democrats are back in power in Congress, and they have their eyes on the drug industry. Look for hearings, investigations, an attack on the Medicare 'non-interference' clause, and a tough PDUFA reauthorization.
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial